Literature DB >> 3480884

Imipenem kinetics in serum, lung tissue and pericardial fluid in patients undergoing thoracotomy.

G Benoni1, L Cuzzolin, C Bertrand, V Puchetti, G Velo.   

Abstract

Imipenem serum pharmacokinetics, lung tissue and pericardial fluid concentrations were measured in 10 patients undergoing thoracotomy, following a 1 g intravenous infusion of imipenem-cilastatin. The serum concentrations of imipenem 0.5 h and 4 h after the end of the 40 min infusion were 53.3 (+/- 16.7) and 2.0 (+/- 0.3) mg/l, respectively. The concentration of imipenem in lung tissue at 1 h was lower than in pericardial fluid and at 2.25 h the mean concentration of imipenem in pericardial fluid was 10.5 mg/l, vs. 0.28 mg/kg of lung tissue. Imipenem concentrations in pericardial fluid remained above 5 mg/l, well above the MIC for most pathogens, for 1 h whereas in pericardial fluid the concentration was 10.5 mg/l at 2.25 h.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3480884     DOI: 10.1093/jac/20.5.725

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid.

Authors:  J G Coen van Hasselt; Matthew L Rizk; Mallika Lala; Cynthia Chavez-Eng; Sandra A G Visser; Thomas Kerbusch; Meindert Danhof; Gauri Rao; Piet H van der Graaf
Journal:  Br J Clin Pharmacol       Date:  2016-04-01       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

3.  Penetration of meropenem in lung, bronchial mucosa, and pleural tissues.

Authors:  B Byl; F Jacobs; I Roucloux; P de Franquen; M Cappello; J P Thys
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

4.  Resistance evolution can disrupt antibiotic exposure protection through competitive exclusion of the protective species.

Authors:  Angus M Quinn; Michael J Bottery; Harry Thompson; Ville-Petri Friman
Journal:  ISME J       Date:  2022-07-20       Impact factor: 11.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.